MCID: THR024
MIFTS: 43

Thrombosis

Categories: Cardiovascular diseases, Blood diseases

Aliases & Classifications for Thrombosis

MalaCards integrated aliases for Thrombosis:

Name: Thrombosis 12 29 52 3 69
Thrombosis of Blood Vessel 69

Classifications:



External Ids:

Disease Ontology 12 DOID:0060903

Summaries for Thrombosis

Disease Ontology : 12 A vascular disease caused by the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system.

MalaCards based summary : Thrombosis, also known as thrombosis of blood vessel, is related to portal vein thrombosis and coronary thrombosis. An important gene associated with Thrombosis is F2 (Coagulation Factor II, Thrombin). The drugs Dalteparin and Heparin have been mentioned in the context of this disorder. Affiliated tissues include liver, heart and testes.

CDC : 3 Many people who have or have had family members with hemophilia will ask that their baby boys get tested soon after birth.

Wikipedia : 72 Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through... more...

Related Diseases for Thrombosis

Diseases related to Thrombosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 810)
id Related Disease Score Top Affiliating Genes
1 portal vein thrombosis 12.3
2 coronary thrombosis 12.2
3 cavernous sinus thrombosis 12.2
4 sagittal sinus thrombosis 12.0
5 lateral sinus thrombosis 12.0
6 carotid artery thrombosis 12.0
7 cerebral sinovenous thrombosis 12.0
8 intracranial thrombosis 12.0
9 intracranial sinus thrombosis 11.9
10 complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy 11.9
11 primitive portal vein thrombosis 11.9
12 pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis 11.7
13 budd-chiari syndrome 11.7
14 thrombophilia due to thrombin defect 11.5
15 thrombophilia, x-linked, due to factor ix defect 11.3
16 heparin-induced thrombocytopenia 11.3
17 thrombophilia 11.3
18 factor v leiden thrombophilia 11.3
19 antiphospholipid syndrome 11.2
20 protein s deficiency 11.2
21 protein c deficiency 11.1
22 post-thrombotic syndrome 11.1
23 dysfibrinogenemia 11.1
24 thoracic outlet syndrome 11.1
25 hereditary antithrombin deficiency 11.0
26 pulmonary embolism 11.0
27 venous thoracic outlet syndrome 11.0
28 systemic lupus erythematosus 11.0
29 essential thrombocythemia 11.0
30 paroxysmal nocturnal hemoglobinuria 11.0
31 thrombophilia due to thrombomodulin defect 11.0
32 thrombocytosis 11.0
33 ischemia 11.0
34 may-thurner syndrome 10.9
35 factor vii deficiency 10.9
36 clopidogrel resistance 10.9
37 retroperitoneal fibrosis 10.9
38 catastrophic antiphospholipid syndrome 10.9
39 chronic venous insufficiency 10.9
40 moyamoya disease 10.9
41 portal hypertension, noncirrhotic 10.9
42 thrombophilia due to protein s deficiency, autosomal recessive 10.9
43 thrombophilia due to activated protein c resistance 10.8
44 shwartzman phenomenon 10.8
45 coumarin resistance 10.8
46 perianal hematoma 10.8
47 erythrocytosis, familial, 2 10.7
48 thrombophilia due to protein s deficiency, autosomal dominant 10.7
49 thrombophilia due to protein c deficiency, autosomal dominant 10.7
50 thrombophilia due to protein c deficiency, autosomal recessive 10.7

Graphical network of the top 20 diseases related to Thrombosis:



Diseases related to Thrombosis

Symptoms & Phenotypes for Thrombosis

Drugs & Therapeutics for Thrombosis

Drugs for Thrombosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 881)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dalteparin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 9005-49-6
2
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 9005-49-6 772 46507594
3
Bivalirudin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 128270-60-0 16129704
4
Tenecteplase Approved Phase 4,Phase 3,Phase 1,Phase 2 191588-94-0
5
Tirofiban Approved Phase 4,Phase 3 144494-65-5 60947
6
Abciximab Approved Phase 4,Phase 3,Phase 2 143653-53-6
7
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-78-2 2244
8
Thrombin Approved Phase 4,Phase 3,Phase 2,Phase 1
9
Rivaroxaban Approved Phase 4,Phase 3,Phase 2,Phase 1 366789-02-8
10
Phenobarbital Approved Phase 4 50-06-6 4763
11
Alprostadil Approved, Investigational Phase 4,Phase 3,Phase 2 745-65-3 149351
12
Tranexamic Acid Approved Phase 4,Phase 3,Phase 2,Phase 1 1197-18-8 5526
13
Tranylcypromine Approved Phase 4,Phase 3 155-09-9 441233
14
Nicorandil Approved Phase 4 65141-46-0 47528
15
Ticagrelor Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 274693-27-5 9871419
16
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 2 50-28-2 5757
17
Norethindrone Approved Phase 4 68-22-4 6230
18
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
19
Salicylic acid Approved, Vet_approved Phase 4,Phase 3,Phase 2 69-72-7 338
20
Warfarin Approved Phase 4,Phase 3,Phase 2,Phase 1 81-81-2 6691 54678486
21
Acenocoumarol Approved Phase 4,Phase 3 152-72-7 9052 54676537
22
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1 55142-85-3 5472
23
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1 73590-58-6 4594
24
Pantoprazole Approved Phase 4,Phase 3,Phase 1 102625-70-7 4679
25
Phenprocoumon Approved Phase 4,Phase 3,Phase 2 435-97-2 9908 54680692
26
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
27
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
28
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 33069-62-4 36314
29
Chromium Approved Phase 4,Phase 2,Phase 3 7440-47-3 27668
30
Nitric Oxide Approved Phase 4,Phase 2,Phase 3,Phase 1 10102-43-9 145068
31
Coal tar Approved Phase 4,Phase 2,Phase 3,Phase 1 8007-45-2
32
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2,Phase 3 55-56-1 9552079 2713
33
Oxaliplatin Approved, Investigational Phase 4,Phase 3,Phase 2 61825-94-3 5310940 9887054 43805 6857599
34
Eptifibatide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 188627-80-7 123610
35
Medroxyprogesterone acetate Approved, Investigational Phase 4,Phase 3 71-58-9
36 Certoparin Approved Phase 4,Phase 3
37
Progesterone Approved, Vet_approved Phase 4,Phase 3 57-83-0 5994
38 Nadroparin Approved Phase 4,Phase 3,Phase 2 9041-08-1
39
Bevacizumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 216974-75-3
40
Ranibizumab Approved Phase 4,Phase 2,Phase 3,Phase 1 347396-82-1 459903
41
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 124-94-7 31307
42
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
43
Tinzaparin Approved Phase 4,Phase 3,Phase 2 9005-49-6, 9041-08-1 25244225
44
Argatroban Approved, Investigational Phase 4,Phase 3,Phase 2 74863-84-6 152951
45
Cisplatin Approved Phase 4,Phase 3,Phase 2 15663-27-1 84093 441203 2767
46
Ethiodized oil Approved Phase 4,Phase 3,Phase 2 8008-53-5
47 Edoxaban Approved Phase 4,Phase 3,Phase 2,Phase 1 480449-70-5
48
Ezetimibe Approved Phase 4 163222-33-1 150311
49
Simvastatin Approved Phase 4,Phase 3,Early Phase 1 79902-63-9 54454
50
Apixaban Approved Phase 4,Phase 3,Phase 2,Phase 1 503612-47-3 10182969

Interventional clinical trials:

(show top 50) (show all 3855)

id Name Status NCT ID Phase Drugs
1 Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis Unknown status NCT00450645 Phase 4 low molecular weight heparin
2 Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis Unknown status NCT01252420 Phase 4 Enoxaparin
3 Rosuvastatin for Preventing Deep Vein Thrombosis Unknown status NCT01021488 Phase 4 Rosuvastatin 20mg/d for 14days;enoxaparin only
4 Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis Unknown status NCT00640731 Phase 4
5 Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty Unknown status NCT02592694 Phase 4 cocktail
6 Re-STOP DVT: Reload of High Dose Atorvastatin for Preventing Deep Vein Thrombosis in Statin Users Unknown status NCT01063426 Phase 4 High dose Atorvastatin+enoxaparin;Enoxaparin
7 Thrombus Aspiration for OcLuded Coronary Artery Enhanced With Distal Injection Of Abciximab Unknown status NCT01383785 Phase 4
8 Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis Unknown status NCT01245998 Phase 4 Dalteparin;Dalteparin
9 Hormones Inflammation and Thrombosis Unknown status NCT01875185 Phase 4 Aspirin 81 mg PO daily x 7 days
10 Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Non-ST-elevation Myocardial Infarction Study Unknown status NCT01013038 Phase 4
11 Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis Unknown status NCT01350206 Phase 4
12 Dissecting the Role of Distal Embolization of Athero-thrombotic Material in Primary PCI: the ThrombOticBurden and mIcrovAscularobStruction (TOBIAS) Study. Unknown status NCT01914055 Phase 4
13 Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis Unknown status NCT02055131 Phase 4 aspirin
14 Evicel Study on the Peri-operative Bleeding in Total Knee Prothesis Surgery Unknown status NCT00983112 Phase 4 Human Fibrinogen and human thrombin (Evicel);Sodium Chlorure (Physiological saline)
15 Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside) Unknown status NCT00963781 Phase 4 Reduced duration (6 months) DAPT
16 Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients. Unknown status NCT01970280 Phase 4 Enoxaparin
17 Rivaroxaban for Antiphospholipid Antibody Syndrome Unknown status NCT02116036 Phase 4 Rivaroxaban
18 Efficacy of Thrombosuction in Primary Percutaneous Coronary Intervention of Acute Myocardial Infarction Unknown status NCT01156662 Phase 4
19 Prolonged Hemodialysis Catheter Survival With Copolymer Coating and Rt-PA Unknown status NCT01670474 Phase 4 rt-PA (2mg/2mL) actilysis;rt-PA
20 Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial Infarction Unknown status NCT01499407 Phase 4 Abciximab
21 The Use of Prostaglandin E1 in Head and Neck Microsurgery Unknown status NCT00733434 Phase 4 Prostaglandin E1
22 Comparison of Topical and Infusion Tranexamic Acid After Total Knee Arthroplasty Unknown status NCT02453802 Phase 4 Tranexamic Acid 5%,5ml/amp;Tranexamic Acid 5%,5ml/amp;rivaroxaban (10mg);0.9% Normal Saline;0.9% Normal Saline
23 Late Incomplete Stent Apposition Evaluation II: Comparison Between Polimer-based and No-polimer Stent System. IVUS Based Study Unknown status NCT01375855 Phase 4
24 Randomised Controlled Trial of Needle Free Access Devices in Preventing Hemodialysis Blood Stream Infection Unknown status NCT01082770 Phase 4
25 Effectiveness of Blood Clot Medication With Concomitant Blood Pressure Medication Unknown status NCT00424281 Phase 4 Arixtra (fondaparinux), 2.5 mg/day-what is bioavailability
26 Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction Unknown status NCT02435797 Phase 4 Nicorandil;normal saline
27 Monitoring Response to Antiplatelet Therapy Unknown status NCT00327041 Phase 4
28 Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy Unknown status NCT02264743 Phase 4 Femoston Conti;EVOREL® CONTI
29 Cost Effectiveness Analysis In Patients With Heart Valve Prosthesis Unknown status NCT02022527 Phase 4 Acetyl Salicylic Acid;Warfarin;Placebo (for Aspirin)
30 Anticoagulation in Stent Intervention Unknown status NCT01141153 Phase 4 Acetylsalicylic Acid + clopidogrel + acenocoumarol;Acetylsalicylic Acid + clopidogrel
31 Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN) Unknown status NCT01735227 Phase 4 omeprazole;Pantoprazole
32 Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation Unknown status NCT00776633 Phase 4 aspirin;clopidogrel;oral anticoagulation
33 Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients Unknown status NCT01198379 Phase 4 aspirin;Placebo
34 Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI Unknown status NCT01781715 Phase 4
35 Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction Unknown status NCT00976092 Phase 4 Prasugrel;Bivalirudin;Clopidogrel;Heparin
36 DEDICA (Dose of HEparin During Coronary Angioplasty) Trial Unknown status NCT01694459 Phase 4 Low-dose heparin;Standard dose heparin
37 EvaluAtion of Predictive Value of Multisite Intracardiac EchoCardiography During Imaging of Structure and funCTION of Left Atrial Appendage in Comparison to Transesophageal Echocardiography Unknown status NCT01371279 Phase 4
38 Reversal of the Antithrombotic Action of New Oral Anticoagulants Unknown status NCT01478282 Phase 4 Rivaroxaban;Dabigatran
39 Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents Unknown status NCT01268371 Phase 4
40 Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI Unknown status NCT02012140 Phase 4 ticagrelor
41 A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction Unknown status NCT01942070 Phase 4
42 Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease Unknown status NCT01418794 Phase 4
43 MGuard Stent in ST-elevation Myocardial Infarction Unknown status NCT01124942 Phase 4
44 Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients Unknown status NCT01610141 Phase 4
45 Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome Unknown status NCT01951001 Phase 4 Prasugrel
46 Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting Unknown status NCT00661206 Phase 4 Clopidogrel;Placebo
47 Microvascular Reperfusion Utilizing Sonothrombolysis in Acute Myocardial Infarction (MRUSMI TRIAL) Unknown status NCT02170103 Phase 4 Microbubbles
48 Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing Unknown status NCT00698607 Phase 4 6-month clopidogrel therapy;12-month clopidogrel therapy
49 ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion Unknown status NCT00407940 Phase 4
50 Assessment of Surface Coverage of Two Types of DES in Diabetes Mellitus and Non- Diabetes Mellitus Unknown status NCT01023919 Phase 4

Search NIH Clinical Center for Thrombosis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Genetic Tests for Thrombosis

Genetic tests related to Thrombosis:

id Genetic test Affiliating Genes
1 Thrombosis 29

Anatomical Context for Thrombosis

MalaCards organs/tissues related to Thrombosis:

39
Liver, Heart, Testes, Endothelial, Lung, Kidney, Brain

Publications for Thrombosis

Articles related to Thrombosis:

(show top 50) (show all 6863)
id Title Authors Year
1
Embolism as a cause of early thrombosis of arteriovenous fistula for hemodialysis. ( 28946971 )
2017
2
Acute kidney injury and risk of deep vein thrombosis and pulmonary embolism in Taiwan: A nationwide retrospective cohort study. ( 28092798 )
2017
3
Tissue Factor Pathway Inhibitor-1 Is a Valuable Marker for the Prediction of Deep Venous Thrombosis and Tumor Metastasis in Patients with Lung Cancer. ( 28246607 )
2017
4
Letter to the Editor: Lateral sinus thrombosis: antithrombotic therapy and the issue of management of cerebellar swelling. ( 27767402 )
2017
5
Portal vein thrombosis after hepatitis C eradication with direct acting antiviral therapy. ( 28782876 )
2017
6
Endovascular treatment of an unusual membranous obstruction of the inferior vena cava in Budd-Chiari syndrome complicated by mural portal vein thrombosis. ( 28483616 )
2017
7
Cerebral venous sinus thrombosis in homocystinuria: Dietary intervention in conjunction with anticoagulation. ( 28835823 )
2017
8
Cerebral Venous Sinus Thrombosis Presenting Feature of Systemic Lupus Erythematosus. ( 28065614 )
2017
9
Cavernous Sinus, Thrombosis ( 28846357 )
2017
10
Plasma cell neoplasm as a risk factor for early thrombosis of arteriovenous fistula. ( 28762615 )
2017
11
Congenital dysfibrinogenemia in a Japanese family with fibrinogen Naples (BI^Ala68Thr) manifesting as superior sagittal sinus thrombosis. ( 28537987 )
2017
12
Combined use of stent-retriever and aspiration thrombectomy for cerebral venous sinus thrombosis involving the straight sinus: A case report. ( 28944707 )
2017
13
Cerebral venous thrombosis as the first presentation of classical homocystinuria in an adult patient. ( 28137899 )
2017
14
A review of eight cases of cavernous sinus thrombosis secondary to sphenoid sinusitis, including a12-year-old girl at the present department. ( 28535728 )
2017
15
Oncostatin M was associated with thrombosis in patients with atrial fibrillation. ( 28471981 )
2017
16
Thrombosis of the Inferior Vena Cava after Endovascular Aortic Repair in a Patient with May-Thurner Syndrome: Case Report and Literature Review. ( 28163175 )
2017
17
Primary Intra-aortic Epstein-Barr Virus-Positive Large B-Cell Lymphoma Presenting as Aortic Mural Thrombosis: An Entity Distinct From Intravascular Large B-Cell Lymphoma. ( 28697692 )
2017
18
GPVIa89Fca89PEG improves cerebral infarct volume and cerebral thrombosis in mouse model with cerebral thrombosis. ( 28944903 )
2017
19
Reduced microperfusion due to portal vein thrombosis: Impact on the outcome of percutaneous thermal tumor ablation. ( 28885205 )
2017
20
Comparison of clinical outcomes of pharmacomechanical thrombectomy in iliac vein thrombosis with and without may-thurner syndrome. ( 28291305 )
2017
21
Effect of Post-procedural Full Does Infusion of Bivalirudin on Acute Stent Thrombosis in Patients with ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Outcomes in a large real-world population. ( 28083915 )
2017
22
Pulmonary embolism and internal jugular vein thrombosis as evocative clues of Lemierre's syndrome: A case report and review of the literature. ( 28352635 )
2017
23
Clinical and In Vitro Evidence That Subclinical Hemolysis Contributes to LVAD Thrombosis. ( 28942075 )
2017
24
Sagittal sinus thrombosis in JAK2-V617F mutation without overt myeloproliferative disorder. ( 28228434 )
2017
25
Thrombosis in adult patients with acute leukemia. ( 28841588 )
2017
26
Postoperative inflammation as a possible cause of portal vein thrombosis after irreversible electroporation for locally advanced pancreatic cancer. ( 28932093 )
2017
27
Multidisciplinary management of testicular cancer complicated by thrombosis of the inferior vena cava: a case report. ( 28678675 )
2017
28
Transcatheter aortic valve thrombosis: incidence, clinical presentation and long-term outcomes. ( 28950318 )
2017
29
Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis. ( 28682164 )
2017
30
Cerebral Sinovenous Thrombosis. ( 28798906 )
2017
31
Unilateral Papilledema in Cerebral Venous Sinus Thrombosis. ( 28936083 )
2017
32
Is real-time elastography helpful to differentiate acute from subacute deep venous thrombosis? A preliminary study. ( 28940429 )
2017
33
Down-regulation of metabolic proteins in hepatocellular carcinoma with portal vein thrombosis. ( 28785178 )
2017
34
Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant. ( 28621635 )
2017
35
Corrigendum: Portal vein thrombosis - a primer for the general physician. ( 28765412 )
2017
36
Odontogenic orbital cellulitis associated with cavernous sinus thrombosis and pulmonary embolism: a case report. ( 28629401 )
2017
37
Portal vein thrombosis after laparoscopic total colectomy for colonic inertia. ( 28928915 )
2017
38
Hepatic infarction from portal vein thrombosis: A fatal consequence of acute pancreatitis. ( 28421699 )
2017
39
Protocol Modification of Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome Study. ( 28893087 )
2017
40
Repeated Prosthetic Mitral Valve Thrombosis in FlukeA Infection Induced Hypereosinophilic Syndrome. ( 28219563 )
2017
41
Sildenafil-related cerebral venous sinus thrombosis and papilledema: a case report of a rare entity. ( 28474148 )
2017
42
A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC. ( 28747069 )
2017
43
Arteriovenous fistula thrombosis with mycobacterial infection. ( 28938943 )
2017
44
PEGylation of Lumbrokinase improves pharmacokinetic profile and enhances antia89thrombotic effect in a rat carotid artery thrombosis model. ( 28791355 )
2017
45
Liver Transplant in Patients with Portal Vein Thrombosis: Medical and Surgical Requirements. ( 28834305 )
2017
46
Predictive Factors for Developing Venous Thrombosis during Cisplatin-Based Chemotherapy in Testicular Cancer. ( 28514776 )
2017
47
Simultaneous Occurrence of Deep Vein Thrombosis and Carotid Artery Thrombosis in Antiphospholipid Antibody Syndrome. ( 28479827 )
2017
48
Transjugular Intrahepatic Portosystemic Shunt as the Treatment for Refractory Hepatic Hydrothorax with Portal Vein Thrombosis. ( 28776556 )
2017
49
CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis. ( 28657829 )
2017
50
Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: A Danish nationwide cohort study. ( 28618892 )
2017

Variations for Thrombosis

Expression for Thrombosis

Search GEO for disease gene expression data for Thrombosis.

Pathways for Thrombosis

GO Terms for Thrombosis

Sources for Thrombosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....